Reference health
Systematic Review: Surveillance for Breast Cancer in Women Treated With Chest Radiation for Childhood, Adolescent, or Young Adult Cancer
73/73 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 73 checked references that resolve
resolves10.1093/jnci/djn310
Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study
resolves10.1200/JCO.2004.11.032
Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline
resolves10.7326/0003-4819-147-8-200710160-00010-w1
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
resolves10.7326/0003-4819-147-8-200710160-00010
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
resolves10.1016/j.ijrobp.2008.03.066
Breast Cancer After Treatment of Hodgkin's Lymphoma: Risk Factors That Really Matter
resolves10.1200/JCO.2003.11.059
High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study Group
resolves10.1200/JCO.2005.06.225
Malignant Breast Tumors After Radiotherapy for a First Cancer During Childhood
resolves10.7326/0003-4819-141-8-200410190-00006
Breast Cancer after Childhood Cancer: A Report from the Childhood Cancer Survivor Study
resolves10.1200/JCO.2000.18.12.2435
Second Cancers Among Long-Term Survivors of Hodgkin’s Disease Diagnosed in Childhood and Adolescence
resolves10.1182/blood-2002-02-0634
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors
resolves10.1002/ijc.22261
Risk of breast cancer in female survivors of childhood Hodgkin's disease in Britain: A population‐based study
resolves10.1016/j.ijrobp.2008.04.067
Subsequent Malignancies in Children Treated for Hodgkin's Disease: Associations With Gender and Radiation Dose
resolves10.1200/JCO.2008.19.9174
Breast Cancer Risk in Female Survivors of Hodgkin's Lymphoma: Lower Risk After Smaller Radiation Volumes
resolves10.1002/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO;2-N
Second malignant neoplasms after cancer in childhood and adolescence: A population-based case-control study in the 5 nordic countries
resolves10.1001/jama.290.4.465
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
resolves10.1093/jnci/dji290
Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin Lymphoma
resolves10.1182/blood-2005-04-1535
Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
resolves10.1200/JCO.2008.20.7738
Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study
resolves10.1086/513891
Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13
resolves10.1086/301749
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
resolves10.1056/NEJM199705153362001
The Risk of Cancer Associated with Specific Mutations of<i>BRCA1</i>and<i>BRCA2</i>among Ashkenazi Jews
resolves10.1186/1478-7954-2-6
Estimating age conditional probability of developing disease from surveillance data
resolves10.1056/NEJM199603213341201
Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease
resolves10.1093/aje/kwg278
A Methodological Issue in the Analysis of Second-Primary Cancer Incidence in Long-Term Survivors of Childhood Cancers
resolves10.1016/S0167-8140(01)00337-1
Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases
resolves10.1159/000012035
Breast Cancer in Women following Supradiaphragmatic Irradiation for Hodgkin’s Disease
resolves10.4065/78.6.708
Risk of Breast Cancer and Breast Cancer Characteristics in Women Treated With Supradiaphragmatic Radiation for Hodgkin Lymphoma: Mayo Clinic Experience
resolves10.1200/JCO.1992.10.11.1674
Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients.
resolves10.1046/j.1524-4741.2001.007001046.x
Clinical and Pathologic Features of Breast Cancers in Women Treated for Hodgkin's Disease: A Case-Control Study
resolves10.1093/annonc/mdl399
Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors
resolves10.1200/JCO.2006.10.5056
Incidence and Prognosis of Synchronous and Metachronous Bilateral Breast Cancer
resolves10.1007/s10549-006-9455-x
Survival after bilateral breast cancer: results from a population-based study
resolves10.1148/radiology.184.2.1320281
Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation.
resolves10.1200/JCO.2002.08.031
Breast Cancer Screening in Women Previously Treated for Hodgkin’s Disease: A Prospective Cohort Study
resolves10.1111/j.1524-4741.2007.00524.x
Mammographic Screening in Women at Increased Risk of Breast Cancer after Treatment of Hodgkin’s Disease
resolves10.1093/annonc/mdm440
Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin’s lymphoma
resolves10.1097/01.coc.0000209447.63640.5a
Breast Cancer Screening in Women Surviving Hodgkin Disease
resolves10.1093/annonc/mdf118
Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review
resolves10.1093/annonc/mdf167
Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review
resolves10.7326/0003-4819-148-9-200805060-00007
Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer
resolves10.1200/JCO.2006.05.8586
The Case for Individualized Screening Recommendations for Breast Cancer
resolves10.3322/canjclin.57.2.75
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
resolves10.1001/jama.292.11.1317
Surveillance of <EMPH TYPE="ITAL">BRCA1</EMPH> and <EMPH TYPE="ITAL">BRCA2</EMPH> Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination
resolves10.1007/s10198-007-0042-9
The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30–49
resolves10.1001/jama.295.20.2374
Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging
resolves10.1016/j.jacr.2008.10.003
Cost Effectiveness of Breast Cancer Screening With Contrast-Enhanced MRI in High-Risk Women
resolves10.1038/sj.bjc.6603356
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer
resolves10.1038/sj.bjc.6602683
Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits
resolves10.1259/bjr.74.888.741121
Cancers detected and induced, and associated risk and benefit, in a breast screening programme
resolves10.1259/bjr.75.896.750678
Concerning the relationship between benefit and radiation risk, and cancers detected and induced, in a breast screening programme
resolves10.1259/bjr/33577478
Radiation benefit and risk at the assessment stage of the UK Breast Screening Programme
resolves10.1259/bjr/20496795
Risk factors for induction of breast cancer by X-rays and their implications for breast screening
resolves10.7326/0003-4819-146-7-200704030-00008
Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians
resolves10.1093/jnci/djn440
Estimated Risk of Radiation-Induced Breast Cancer From Mammographic Screening for Young BRCA Mutation Carriers
resolves10.1158/1055-9965.EPI-06-0176
Effect of Mammography on Breast Cancer Risk in Women with Mutations in <i>BRCA1</i> or <i>BRCA2</i>
resolves10.1016/S1470-2045(06)70624-6
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
resolves10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2
Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight Cohorts
resolves10.1259/bjr/41095952
Radiation doses received in the UK Breast Screening Programme in 2001 and 2002
resolves10.1093/rpd/nci766
Mammographic breast cancer screening for women previously treated with high breast doses for diseases such as Hodgkin's
resolves10.1002/cncr.23081
Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma
resolves10.1001/jama.2008.1039
Breast Cancer Surveillance Practices Among Women Previously Treated With Chest Radiation for a Childhood Cancer
resolves10.1001/jama.297.24.2762
Childhood Cancer Survivors, Late Effects, and a New Model for Understanding Survivorship
resolves10.1001/jama.297.24.2705
Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.7326/0003-4819-152-7-201004060-00009"><img src="https://citestamp.com/citestamped/10.7326/0003-4819-152-7-201004060-00009/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.7326/0003-4819-152-7-201004060-00009)